Abstract:Context: Diabetic nephropathy (DN) is a common microvascular complication in diabetic patients. The pathogenesis of DN is complex. Inflammatory response may play a key role as a common downstream pathway. Objective: The study intended to explore the relationship between the levels of plasma nucleotide-binding oligomeric domain-like receptor protein 3 (NLRP3 inflammasome), interleukin-1β (IL-1β), and IL-18 and the progression of type 2 diabetic nephropathy to clarify their relationship with type 2 diabetes mellitus (T2DM) and to provide evidence for clinical treatment. Design: The research team performed a controlled observational study. Setting: The study took place at Baoding No. 1 Central Hospital in Baoding, Hebei, China. Participants: Participants were 153 patients with T2DM who received treatment at the hospital between October 2020 and October 2021. The research team allocated 30 participants without evidence of DN to the control group. Based on the DN stage, the team assigned the 123 remaining participants to one of five observation groups: (1) 32 participants with stage 1 DN to the DN1 group, (2) 31 participants with stage 2 DN to the DN2 group, (3) 30 participants with stage 3 DN to the DN3 group, (4) 30 participants with stage 4 DN to the DN4 group, and (5) 29 participants with stage 5 DN to the DN5 group. Outcome measures: The research team measured participants' levels of "nucleotide binding oligomeric domain-like receptor protein 3" (NLRP3), interleukin-1 beta (IL-1β), and IL-18 and used the Spearman rank correlation analysis to determine the correlation between those levels and the DN stages. Results: The levels of NLRP3 , IL-1β and IL-18 in all the five observation groups were significantly higher than those in the control group (all P < .01). The levels were also significantly higher: (1) in the DN2, DN3, DN4, and DN5 groups than those in the DN1 group (all P < .01); (2) in the DN3, DN4, and DN5 groups than those in the DN2 group (all P < .01); (3) in the DN4 and DN5 groups than those in the DN3 group (all P < .01); and (4) in the DN5 groups than those in the DN4 group (all P < .01). The Spearman rank correlation analysis showed that the NLRP3, IL-1β, and IL-18 levels were significantly positively correlated with the DN stage (P = .01). Conclusions: NLRP3, IL-1β and IL-18 played an important role in the progression of T2DM, and their levels increased with the aggravation of DN. Therefore, the plasma levels of NLRP3, IL-1β and IL-18 can be useful as indicators of the occurrence and development of DN and can provide clinical guidance for the early diagnosis of DN and for the determination and adjustment of treatment plans.

Detection of TNF-α,IL-18 and ADPN in Type 2 Diabetic Patients with Nephropathy

Depiction of Immune Heterogeneity of Peripheral Blood from Patients with Type II Diabetic Nephropathy Based on Mass Cytometry

Clinical Significance of Determination of Serum Cystatin C,lipoprotein (α) and High Sensitivity C-reactive Protein in Type 2 Diabetic Patients with Early Renal Impairment.

Correlation Between Plasma NLRP3, IL-1β, and IL-18 and Diabetic Nephropathy in Patients With Type 2 Diabetes

Clinical Characteristics of Diabetic Nephropathy in Patients with Type 2 Diabetic Mellitus Manifesting Heavy Proteinuria: a Retrospective Analysis of 220 Cases.

Clinical Analysis on Changes of Nitric Oxide(no),endothelin(et),thromboxane A2 and Prostaglandin I2 in Type 2 Diabetic Nephropathy

Clinical significance of combined detection of plasma CD146 and P-selectin in patients with type 2 diabetic nephrophathy

Application value of DD ,Fib ,Hcy and Cys-C in early diagnosis of type 2 diabetic nephropathy

Serum and Urinary Metabolomic Analysis in Patients with Diabetic Nephropathy

Serum soluble tumor necrosis factor receptor levels in T2DM patients with early diabetic kidney disease and the clinical implications

Differences In Serum Amino Acid Phenotypes Among Patients With Diabetic Nephropathy, Hypertensive Nephropathy, And Chronic Nephritis

Detection of glycated albumin and its related metabolic markers in patients with type 2 diabetes mellitus or diabetic nephropathy and clinical significance

TNF-? and IL-1? Promote Renal Podocyte Injury in T2DM Rats by Decreasing Glomerular VEGF/eNOS Expression Levels and Altering Hemodynamic Parameters

Association of TNF-αG-308A gene polymorphism with pathogenesis of type 2 diabetic nephropathy

Analysis of the Variation Levels of APN, Insulin, Sensitive C-Reactive Protein and Leptin in the Serum of Patients with Type 2 Diabetes Mellitus

The Relationship Among Plasma Adiponectin,Apolipoprotein A5 and Type 2 Diabetic Patients

Levels of Inflammatory Cytokines in Type 2 Diabetes Patients with Different Urinary Albumin Excretion Rates and Their Correlation with Clinical Variables

Clinical significance of detection of serum homocysteine, lipoprotein α, cystatin C,high sensitivity C - reactive protein in diabetic nephropathy patients

Exploring the relations of NLR, hsCRP and MCP-1 with type 2 diabetic kidney disease: a cross-sectional study

Role of serum β2-microglobulin, glycosylated hemoglobin, and vascular endothelial growth factor levels in diabetic nephropathy

Role of Beta Trace Protein and Cystatin C as a Potential Biomarker for Early Detection of Type 2 Diabetic Nephropathy